ADS Biotec, along with its parent company ADSTEC (Japan), is a global leader in the development, manufacture and sale of automated instruments and consumables for use in cytogenetic, pathology and research laboratories.

TIDES Europe | November 12-14, 2024

  • 10/09/2024
  • 553 Views

 

The TIDES Europe: Oligonucleotide & Peptide Therapeutics is the Industry’s leading even in Europe to Accelerate Therapeutics to market by expediting R&D, Improving CMC Efficiency, and Building New Partnerships. The TIDES Europe 2024 hybrid program features scientific tracks covering in-depth development strategies, trends and technologies across the entire oligonucleotide and peptide spectrum and areas of focus such as: Oligonucleotide Chemistry, Manufacturing & controls, Oligonucleotide Discovery, Preclinical and Clinical, Peptide Chemistry, Manufacturing & controls, Peptide Discovery, Preclinical and Clinical, mRNA Therapeutics and Genome Editing, and Macromolecular Drug Delivery.

Event details

This year’s meeting will be a big event for ADS Biotec, providing an opportunity for collaboration, learning, and celebration. Here’s a sneak peek of what’s in store:

  • Kick-off: Let’s celebrate our wins and share some opportunities as we reflect on the highlights of the past year.
  • New products: Visit our Booth to find out about our New Products

More details to follow! Come and visit us at our booth!
November 12-14, 2024 in Hamburg Germany

RESOURCES

LOCATION

Hamberg Congress Center
Marseiller Promenade 1 · 20355 Hamburg

Want to see more events that ADS Biotec will be attending? Check out our Events page